Trademark Overview
On Thursday, August 3, 2023, a trademark application was filed for ONCOSIGNATURE with the United States Patent and Trademark Office. The USPTO has given the ONCOSIGNATURE trademark a serial number of 98115652. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Wednesday, June 5, 2024. This trademark is owned by Acrivon Therapeutics, Inc.. The ONCOSIGNATURE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy predication and analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits or does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes
Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, consultancy and advisory services; individual medical counseling services provided to patients; providing a website featuring information in the fields of oncology and precision medicine; providing medical information to medical professionals in the form of reports in the fields of oncology and precision medicine
